206 related articles for article (PubMed ID: 29790240)
21. Hormonal influence on HIV-1 transmission in the female genital tract: New insights from systems biology.
Dupont HA; Lam J; Woods MW; Zahoor MA; Kaushic C
Am J Reprod Immunol; 2018 Aug; 80(2):e13019. PubMed ID: 30014538
[TBL] [Abstract][Full Text] [Related]
22. Genital inflammation, immune activation and risk of sexual HIV acquisition.
Passmore JA; Jaspan HB; Masson L
Curr Opin HIV AIDS; 2016 Mar; 11(2):156-62. PubMed ID: 26628324
[TBL] [Abstract][Full Text] [Related]
23. Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach.
Vishwanathan SA; Burgener A; Bosinger SE; Tharp GK; Guenthner PC; Patel NB; Birse K; Hanson DL; Westmacott GR; Henning TR; Radzio J; Garcia-Lerma JG; Ball TB; McNicholl JM; Kersh EN
J Virol; 2015 Sep; 89(18):9167-77. PubMed ID: 26109722
[TBL] [Abstract][Full Text] [Related]
24. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
[TBL] [Abstract][Full Text] [Related]
25. Vaginal microbiota and its role in HIV transmission and infection.
Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
[TBL] [Abstract][Full Text] [Related]
26. Current concepts of HIV transmission.
Morrow G; Vachot L; Vagenas P; Robbiani M
Curr HIV/AIDS Rep; 2007 Feb; 4(1):29-35. PubMed ID: 17338858
[TBL] [Abstract][Full Text] [Related]
27. The barrier to HIV transmission provided by genital tract Lactobacillus colonization.
Mirmonsef P; Spear GT
Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438
[TBL] [Abstract][Full Text] [Related]
28. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
Cole AM; Cole AL
Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
[TBL] [Abstract][Full Text] [Related]
30. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
Broliden K
J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
[TBL] [Abstract][Full Text] [Related]
31. Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.
Pyles RB; Vincent KL; Baum MM; Elsom B; Miller AL; Maxwell C; Eaves-Pyles TD; Li G; Popov VL; Nusbaum RJ; Ferguson MR
PLoS One; 2014; 9(3):e93419. PubMed ID: 24676219
[TBL] [Abstract][Full Text] [Related]
32. The vaginal microbiome amplifies sex hormone-associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption.
Bradley F; Birse K; Hasselrot K; Noël-Romas L; Introini A; Wefer H; Seifert M; Engstrand L; Tjernlund A; Broliden K; Burgener AD
Am J Reprod Immunol; 2018 Jul; 80(1):e12863. PubMed ID: 29709092
[TBL] [Abstract][Full Text] [Related]
33. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
[TBL] [Abstract][Full Text] [Related]
34. HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.
Cole AM; Cole AL
Viruses; 2017 May; 9(5):. PubMed ID: 28505117
[TBL] [Abstract][Full Text] [Related]
35. HIV's vagina travelogue.
Boggiano C; Littman DR
Immunity; 2007 Feb; 26(2):145-7. PubMed ID: 17307703
[TBL] [Abstract][Full Text] [Related]
36. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
37. Microbiome in normal and pathological pregnancies: A literature overview.
Taddei CR; Cortez RV; Mattar R; Torloni MR; Daher S
Am J Reprod Immunol; 2018 Aug; 80(2):e12993. PubMed ID: 29873429
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
[TBL] [Abstract][Full Text] [Related]
39. Mucosal Dendritic Cell Subsets Control HIV-1's Viral Fitness.
Nijmeijer BM; Langedijk CJM; Geijtenbeek TBH
Annu Rev Virol; 2020 Sep; 7(1):385-402. PubMed ID: 32991263
[TBL] [Abstract][Full Text] [Related]
40. The vaginal microbiota and susceptibility to HIV.
Buve A; Jespers V; Crucitti T; Fichorova RN
AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
